— The American Society of Clinical Oncology, a research group that promotes a better understanding of cancer and other cancers, released a report Thursday that found the vaccine could reduce the risk of contracting the deadly coronavirus.

The group noted that the study looked at people who were infected with Ebola and that it had not yet been tested on those who did not have Ebola.

However, the report said, if that was the case, the vaccine might have a greater than 50% chance of preventing transmission in people who already have Ebola, and in those who are too sick to get tested.

A vaccine that kills all the cells of the virus in the body and then sends a signal to the immune system to stop the virus from spreading could help the immune systems of millions of people in the United States, according to the report.

In its report, the group said that the virus had not spread to any other country.

But the report noted that there was evidence that some countries, including France and the United Kingdom, have used vaccines to halt the spread of Ebola.

The U.K. has not used a vaccine.

Dr. Jonathan Eisenberg, a professor at Harvard Medical School who has worked with the American Society, said the report “makes a strong case for using this vaccine.”

The report noted the vaccine had been approved in the U.S. for use in pregnant women, nursing mothers and people who are in a high-risk group such as those with HIV.

It also said the vaccine would not harm people with Ebola, even in people with high-level antibodies.

While the report did not discuss the effectiveness of the vaccine, Eisenberg said the study showed that the vaccine worked in people in an Ebola-free area.

Eisenberg said that if the U to use a vaccine, it should be a one-shot vaccine, meaning that a person who is already infected with the virus could be given the vaccine and be protected.

“This vaccine is a one shot, which means it’s designed to be used in the first 24 hours,” he said.

At the moment, the United Nations has not issued a blanket ban on the use of the Ebola vaccine.

Instead, the U., China, France, the European Union and the U